Targeted Oncology |
Initiating Ruxolitinib for Polycythemia Vera
Targeted Oncology Jamile M. Shammo, MD: If this patient continues to demonstrate high hematocrit, despite increasing the dose and despite phlebotomy, I would look for other evidence of myeloproliferation; perhaps enlarging spleen, constitutional symptoms. Then, I think ... |
from phlebotomy - Google News http://bit.ly/2psrO1C
No comments:
Post a Comment